在被诊断为晚期心力衰竭的患者中,所有原因死亡的危险因素:范围审查
Palvinder Kaur1, Pradeep Paul George1, Sheryl Ng Hui Xian1
1Health Services and Outcomes Research, National Healthcare Group, Singapore, Singapore.
Journal of palliative medicine
|July 31, 2024
概括
识别患有晚期心力衰竭 (AdHF) 的高风险患者对于及时的息治疗至关重要. 这次审查确定了AdHF的风险因素和预后模型,旨在改善以患者为中心的护理和生存预测.
科学领域:
- 心脏病学 心脏病学
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 晚期心力衰竭 (AdHF) 患者的需求正在不断发展,需要更好的风险分层,以便及时转诊息治疗.
- 有限的预后模型存在,专门用于末期心力衰竭 (HF) 种群.
- 准确的风险评估促进了个性化,以患者为中心的护理,并改善了结果.
研究的目的:
- 在ADHF患者中确定与高达三年全因死亡率 (ACM) 相关的风险因素.
- 描述在ADHF群体中开发或验证的预后模型.
- 提供及时的息护理转诊信息,并加强患者管理策略.
主要方法:
- 根据Arksey,O'Malley和Levac框架进行了范围审查.
- 搜索了多个数据库 (Medline,EMBASE,PubMed,CINAHL,Cochrane,科学网) 和灰色文献 (2010年1月至2020年9月).
- 包括成人 (≥18岁) 患有ADHF (NYHA类III/IV,AHA/ACC阶段D) 的初级研究,使用多变量分析评估ACM的风险因素.
主要成果:
- 在65篇文章中 (低至中等偏差) 确定了多达三年的ACM和预后模型的167个风险因素.
- 研究主要来自西方/欧洲队列,在急性护理环境中,并来自临床试验.
- 十个预后模型显示了可接受的性能 (AUC:0.71-0.81),其中MELD-XI和ADHF/proBNP模型显示了最高的短期ACM歧视 (AUC:0.81).
结论:
- 对于ADHF患者有几种风险因素和预后模型可用,尽管研究主要以西方为中心和急性护理为重点.
- MELD-XI和ADHF/proBNP模型显示出预测AdHF中短期ACM的前景.
- 需要进一步的研究来开发和验证反映当前ADHF管理环境的预后模型,以便及时整合息护理.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
Factors affecting Blood pressure
3.1K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.1K


